| NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply. Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) (RFA-CA-22-020)
Application Receipt Date(s): June 17, 2022 Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed) (RFA-AI-22-020)
Application Receipt Date(s): July 1, 2022 Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) (RFA-OD-22-008)
Application Receipt Date(s): July 1, 2022 A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)(RFA-EY-22-001)
Application Receipt Date(s): July 6, 2022 Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) (PAR-22-147)
Application Receipt Date(s): July 8, 2022 Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) (RFA-AI-22-028)
Application Receipt Date(s): July 29, 2022 Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) (RFA-CA-22-016)
Application Receipt Date(s): September 27, 2022 Alcohol Health Services Research (R01 Clinical Trial Optional) (PAR-22-156)
Application Receipt Date(s): Multiple dates, see announcement. Alcohol Health Services Research (R34 Clinical Trial Optional)Â (PAR-22-157)
Application Receipt Date(s): Multiple dates, see announcement. Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) (PAR-22-158)
Application Receipt Date(s): Multiple dates, see announcement. Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) (PAR-22-159)
Application Receipt Date(s): Multiple dates, see announcement. INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) (RFA-OD-22-007)
Application Receipt Date(s):Â Multiple dates, see announcement. Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)) (RFA-OD-22-009)
Application Receipt Date(s): Multiple dates, see announcement. Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)Â (RFA-OD-22-010)
Application Receipt Date(s): Multiple dates, see announcement. Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)Â (PAR-22-161)
Application Receipt Date(s): Multiple dates, see announcement. Laboratories to Optimize Digital Health (R01 Clinical Trial Required) (PAR-22-154)
Application Receipt Date(s): Multiple dates, see announcement. NIH funding opportunities for which foreign components may apply: Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) (RFA-DA-23-002)
Application Receipt Date(s): August 11, 2022 NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) (RFA-RM-22-019)
Application Receipt Date(s): August 19, 2022 NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (RFA-DC-23-001)
Application Receipt Date(s): August 4, 2023 Other Funding News General NIH notices that may be of interest to global health researchers: Notice to Include Additional Application Due Dates for NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) Request for Information (RFI): Identification of a Set of Determinants for Whole Person Health Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Advancing Research in Immuno-oncology, Immunoprevention, and/or Immunotherapy Notice of changes to funding opportunities that may be of interest to global health researchers: Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)" (NOT-HL-22-021) Notice of Early Expiration of NOT-MH-22-085 Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Inform the Assessment of Suicide Thoughts and Behaviors among Children and Preteens (NOT-MH-22-196)
Notices of intent to publish funding opportunities that may be of interest to global health researchers: Precision Approaches in Radiation Synthetic combinations (PAIRS, R01 Clinical Trial Optional) (NOT-CA-22-078) Precision Approaches in Radiation Synthetic combinations (PAIRS, R21 Clinical Trial Optional) (NOT-CA-22-079) Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (NOT-MH-22-210) Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (NOT-MH-22-211) Non-NIH funding opportunities that may be of interest to global health researchers: The South African Fulbright Foreign Student Program  provides grants for South African university graduates to pursue post-graduate studies at a United States university in any subject (excludes MBA and studies that require contact with patients).
Application deadline: May 1, 2022 The Pandemic Antiviral Discovery initiative is requesting proposals for molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs targeting virus and/or host-specific targets important for virus replication.
Application deadline: May 5, 2022 The  Global Burden of Disease (GBD) Emerging Researcher Award supports emerging global health researchers to carry out innovative research to improve the measurement and knowledge about burden of disease in populations Nomination deadline: May 15, 2022. Heat adaptation: evaluating interventions to help manage the health effects of heat from the Wellcome Trust will fund teams led by researchers from low- or middle-income countries (LMIC) to test interventions to manage heat-related health risks in real settings â not under laboratory conditions.
Preliminary deadline: May 31, 2022 The National Science Foundation (NSF) Convergence Accelerator has issued a new funding opportunity for three new research track topics: Enhancing Opportunities for Persons with Disabilitiesâ¯, Sustainable Materials for Global Challenges, and Food and Nutrition Security
Letter of Intent Due: May 31, 2022 Featured Fogarty News and Information Grantees study masculine norms to reduce violence, Global Health Matters, Jan/Feb 2022 NIH, Fogarty see budget increases for Fiscal Year 2022, Global Health Matters, Mar /Apr 2022 View all Fogarty news View and subscribe to Fogarty's Global Health Matters e-newsletter Other NIH News Antibodies recognize new SARS-CoV-2 Omicron variant after booster
NIH news, April 5, 2022 Events Training and events for global health researchers: April 11â13:
One Health European Joint Programme Annual Scientific MeetingÂ
Virtual and Orvieto, Italy April 14:
Webinar: Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
Hosted by the Center for Global Health (CGH) at the National Cancer Institute (NCI) April 14:
Webinar: Submission and Peer Review of NIH Grant Applications for Global Mental Health Research
Hosted by the Center for Global Mental Health Research at the National Institute of Mental Health (NIMH) April 18â19:
Workshop: The Brain Across the Lifespan: Tools and Methodologies Â
Hosted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Virtual Fogarty calendar of events More Information View all Fogarty funding opportunities Search all NIH funding opportunities and notices Subscribe to NIH Guide for Grants and Contracts weekly emails | 